Find support groups, events and resources near you

ZERO Summit 2021 banner

BiTE Technology in Immuno-Oncology

Graphic about BiTE technology

Doctor Michael Groaning of Amgen discusses a new, groundbreaking immuno-oncology platform - Bispecific T-cell engager technology, or BiTE.

This session was part of our VIRTUAL ZERO Prostate Cancer Summit, a free online event that took place from February 28 to March 4, 2021.


Watch

Contributors

Share